title: [Mechanism of inhibitory effect of angiostatin on plasminogen activation by its physiologic activators].
abstract: The influence of angiostatin K1-4.5--a fragment of the heavy chain of plasmin and a powerful inhibitor of angiogenesis--on kinetic parameters (k(Pg) and K(Pg)) of human Glu-plasminogen activation under the action of urokinase (uPA) not having affinity for fibrin and fibrin-specific tissue plasminogen activator (tPA) was investigated. Angiostatin does not affect the k(Pg) value, but increases the value K(Pg) urokinase plasminogen activation. A decrease in the k(Pg) value and an increase in the K(Pg) value were found for fibrin-stimulated plasminogen activation by tPA with increasing concentrations of angiostatin. The obtained results show that angiostatin is competitive inhibitor of the uPA activator activity, while it inhibits the activator activity of tPA by mixed type. Such an influence ofangiostatin on the kinetic constants ofthe urokinase plasminogen activation suggests that angiostatin dose dependent manner replaces plasminogen in the binary enzyme-substrate complex uPA-Pg. In case of fibrin-stimulated plasminogen activation by tPA, both zymogen and tPA are bound to fibrin with formation of the effective triple tPA-Pg-fibrin complex. Angiostatin replaces plasminogen both from the fibrin surface and from the enzyme-substrate tPA-Pg complex that leads to a decrease in k(Pg) and an increase in K(Pg) of plasminogen activation. Inhibition constants by angioststin (Ki) of plasminogen-activator activities of uPA and tPA determined by Dixon method were found to be 0.59 +/- 0.04 and 0.12 +/- 0.05 microM, respectively.
authors: R B
authors: RB
authors: Aĭsina
authors: L I
authors: LI
authors: Mukhametova
authors: N V
authors: NV
authors: Prisiazhnaia
authors: D A
authors: DA
authors: Gulin
authors: M Iu
authors: MIu
authors: Levashov
authors: K B
authors: KB
authors: Gershkovich
mesh_terms: D043168:Angiostatins / Q000494:pharmacology / Q000502:physiology*; D005337:Fibrin / Q000494:pharmacology; D005341:Fibrinolysin / Q000037:antagonists & inhibitors* / Q000502:physiology; D006801:Humans; D018919:Neovascularization, Physiologic; D010958:Plasminogen / Q000037:antagonists & inhibitors* / Q000502:physiology; D010959:Tissue Plasminogen Activator / Q000494:pharmacology / Q000502:physiology; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology / Q000502:physiology
chemical_list: D043168:Angiostatins; D005337:Fibrin; D010958:Plasminogen; D010959:Tissue Plasminogen Activator; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator